NMTC (NeuroOne Corp) Company Projected Revenue
NeuroOne Medical Technologies (NMTC) reputation as a creator of precision neuromodulators for epilepsy treatment is confirmed by the product sales dynamics on the GURU.Markets chart, where the 0.01 level records fresh values. Current growth is supported by FDA approval and the flexibility of new electrodes, allowing the brand to scale B2B distribution and commercialize ablation systems.
Analytical breakdowns and data insights for company NeuroOne Corp (NMTC)
- current price and projected stock value:
- business market valuation indicators:
- balance sheet equity data:
- issuer credit burden and liquidity indicators:
Total Debt to Capital NeuroOne Medical Technologies|NMTC - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital n1mtc.com|NMTC - Company Total Debt|Debts to Book Capitalization NeuroOne Corp|NMTC - Company Long-Term Debts|Company Short-Term Debt NeuroOne Medical Technologies|Quick Liquidity Indicator n1mtc.com
- earnings and market ratios statistics:
NMTC - Final Profit|Projected Future Earnings NeuroOne Medical Technologies|NMTC - Market Cap to Earnings|Future Price to Earnings NeuroOne|NMTC - Price to Net Income Growth Ratio|Enterprise Value to EBITDA Ratio NeuroOne Corp|NMTC - Operating profit EBITDA|Net earnings per share (EPS TTM) NeuroOne Medical Technologies|NMTC - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months n1mtc.com|NMTC - Earnings per share trend in current year|Net earnings per share growth forecast for next year NeuroOne Medical Technologies
- sales and revenue data:
Fundamental company analysis:n1mtc.com
This metric assesses the projected cash flow from product sales, determining the business's resilience to operational shocks. It measures the potential for revenue scaling by analyzing sales recovery rates following downturns. Future sales revenue for NeuroOne Medical Technologies (NMTC) reflects the commercial impact of neurostimulator implementation and FDA approvals. This price action confirms the effectiveness of the partnership with Zimmer Biomet, allowing for a balance between capital risk and growth potential.
Analysis of competing companies
Company Projected Revenue Boston Scientific Corp (BSX)|EW - Company Expected Sales Volume|Projected Sales Volume RMD (resmed.com)|PODD - Company Future Sales Volume|Zimmer Biomet Holdings, Inc. - Projected Sales Volume|COO (The Cooper Companies) - Company Revenue Forecast|ALGN: Projected Sales Volume|Company Revenue Forecast GMED|TMDX (TransMedics Corp) - Projected Sales Volume|ATEC Spine (ATEC) - Company Future Sales|Projected Sales Volume AORT|Company Future Sales Volume Enovis Corporation ENOV|Projected Sales Volume IART (integralife.com)|Projected Sales Volume Establishment Labs Corp ESTA|BBNX - Company Projected Revenue|IRMD: Company Projected Revenue|EMBC (Embecta Corp.) - Company Future Sales Volume|Tandem Diabetes Care - Company Future Revenue|AXGN (Axogen Surgical) - Projected Sales Volume|Company Expected Sales Volume SI-BONE Inc SIBN|Company Projected Revenue Orthofix Medical (OFIX)|Projected Sales Volume Bioventus Corp (BVS)|OrthoPediatrics Corp - Company Future Sales Volume|Projected Sales Volume Treace Medical Concepts TMCI|Blade Air Mobility - Projected Sales Volume|Company Future Sales Carlsmed, Inc. CARL|RxSight (RXST) - Company Projected Revenue|Company Expected Revenue CLPT (ClearPoint)|Company Projected Revenue stereotaxis.com|Company Future Sales Volume Neuronetics, Inc. (STIM)|Projected Sales Volume SGHT|OBIO - Company Expected Sales Volume|Company Projected Revenue anikatherapeutics.com ANIK|NSPR: Company Revenue Forecast|ZJYL: Company Future Sales Volume|Vivani Medical Inc - Company Projected Revenue Volume|XTNT (Xtant Medical Holdings) - Company Future Sales Volume|Company Future Sales Volume Modular Med|Company Projected Revenue myomo.com|Company Revenue Forecast COCH (Envoy Medical, Inc.)|Company Future Sales Volume VVOS (Vivos Therapeutics)|Company Projected Revenue NVNO (enVVeno Medical Corp.)|Sintx Technologies, Inc. - Company Future Sales Volume|Tenon Medical Inc. (TNON) - Company Expected Sales Volume|LFWD - Company Projected Revenue|AMIX (Autonomix Medical) - Company Revenue Forecast|IVF: Projected Sales Volume|BBLG (Bone Biologics) - Company Projected Revenue|Company Projected Revenue Axonics Inc.|Company Expected Sales Volume Biolase, Inc. BIOL|Company Projected Revenue Dynatronics Corp. (DYNT)|FNA (Paragon 28 Corp) - Company Future Revenue|Company Projected Revenue invobioscience.com INVO
